Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Samsung Shares Rise on $72 Billion Shareholder Return Plan 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Coty Revenue Beats Estimates as Beauty Demand Holds Firm 
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
OpenAI Tightens AI Safety Monitoring After Security Incidents 
Welspun Corp Shares Hit Record High on $1.8 Billion U.S. Order 
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks 
Alibaba Shares Fall as AI Spending Hits Profit 
SK Hynix Shares Surge on Record $28.6 Billion Buyback 
Anthropic IPO Could Challenge SpaceX’s Record $86 Billion Offering 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
Add as a preferred source on Google
CUPERTINO, CA, May 04, 2018 -- Aemetis, Inc. (NASDAQ: AMTX) today announced that Eric McAfee, Chairman and CEO, is scheduled to present on Wednesday, May 9, 2018 at the Disruptive Growth & Healthcare Conference in New York. The conference will be held at the Reed Smith office in New York City.
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
External Investor Relations
Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
Company Investor Relations/
Media Contact:
Todd Waltz
(408) 213-0940
